Latest News

Scientist Aims to Unravel Long COVID’s Neurologic Impacts


 

How Physician Can Treat Common Symptoms Now

Though a cure for symptoms still eludes the scientific community, recent evidence has suggested that a combination of N-acetyl cysteine (NAC) and guanfacine has been successful in easing neurologic symptoms.

In November 2023, Arman Fesharaki-Zadeh, MD, PhD, a Yale Medicine behavioral neurologist and neuropsychiatrist, published a small study in Neuroimmunology Reports with his colleague, Yale neuroscientist Amy Arnsten, PhD. The two researchers showed how among 12 patients given 600 mg NAC daily, along with 1 mg guanfacine (increased to 2 mg after a month if well-tolerated), eight demonstrated improved cognitive abilities.

In patients who stayed on guanfacine + NAC, improved working memory, concentration, and executive functions were seen.

Also, they resumed their normal work schedule. Interruption and inability to work has been a significant factor in the lower quality-of-life long COVID patients experience.

Placebo-controlled trials will be needed going forward, but their small study has established safety and could open up a larger study in the future. For the moment, NAC can be gotten over the counter, and patients could get a prescription off-label from their doctor.

Dr. McAlpine has seen this combination work well for her own patients at Yale’s NeuroCOVID clinic.

Additionally, lifestyle practices such as quitting tobacco, increased exercise, exercising the mind, lowering alcohol intake, and even vitamin D supplementation (1000-2000 IU daily) could prove beneficial in tamping down persistent brain fog.

Vitamin D supports brain and nerve function through its reduction of brain aging biomarkers, regulating genes important for brain function, activating and deactivating enzymes important for neurotransmitter synthesis, and supporting neuronal growth and survival.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

For Some MDs, Long COVID Burnout Is a New Reality
MDedge Internal Medicine
4 Years In, a Sobering Look at Long COVID Progress
MDedge Internal Medicine
NIH to Begin Long COVID Trial Focused on Sleep, Exercise
MDedge Internal Medicine
The Push to Get More People Into Long COVID Studies
MDedge Internal Medicine
MDs’ One-Word Summary of Long COVID Progress: ‘Frustration’
MDedge Internal Medicine
National Academies Issue New Broad Definition of Long COVID
MDedge Internal Medicine
Long COVID Can’t Be Solved Until We Decide What It Is
MDedge Internal Medicine
Cold or Flu Virus May Trigger Relapse of Long COVID
MDedge Internal Medicine
Almost 10% of Infected Pregnant People Develop Long COVID
MDedge Internal Medicine
Long COVID & Chronic Fatigue: The Similarities are Uncanny
MDedge Internal Medicine